C12Y 108/0401
Adenylyl-sulfate reductase
Official title: Adenylyl-sulfate reductase (thioredoxin) (1.8.4.10)
C12Y108/0401 (Adenylyl-sulfate reductase) appears on 8 US grants and 16 published applications in this corpus.
Search patents in C12Y- Granted patents
- 8
- Published applications
- 16
- Assignees
- 9
- Inventors
- 16
- Latest grant
- 14 Apr 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2004 | 0 | 1 |
| 2005 | 0 | 1 |
| 2006 | 0 | 0 |
| 2007 | 1 | 0 |
| 2008 | 0 | 1 |
| 2009 | 1 | 1 |
| 2010 | 0 | 0 |
| 2011 | 0 | 0 |
| 2012 | 0 | 0 |
| 2013 | 0 | 1 |
| 2014 | 1 | 1 |
| 2015 | 1 | 2 |
| 2016 | 1 | 2 |
| 2017 | 0 | 2 |
| 2018 | 1 | 0 |
| 2019 | 0 | 1 |
| 2020 | 0 | 0 |
| 2021 | 0 | 1 |
| 2022 | 0 | 0 |
| 2023 | 0 | 1 |
| 2024 | 0 | 0 |
| 2025 | 1 | 0 |
| 2026 | 1 | 1 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Biocatalyst as a core component of an enzyme-catalyzed redox system for the biocatalytic reduction of cystine14 Apr 2026US 12,600,995 B2Wacker Chemie AG
- Product and process for mucus viscosity normalization19 Aug 2025US 12,390,511 B2Orpro Therapeutics, Inc.
- Modulation of tissue transglutaminase activation in disease3 Jul 2018US 10,010,541 B2The Board of Trustees of the Leland Stanford Junior University
- Product and process for liquefaction of mucus or sputum22 Mar 2016US 9,289,471 B2National Jewish Health
- Product and process for mucus viscosity normalization27 Oct 2015US 9,168,290 B2Orpro Therapeutics, Inc.
- Product and process for mucus viscosity normalization29 Jan 2026US 2026/0027189 A1Orpro Therapeutics, Inc.
- Biocatalyst as a core component of an enzyme-catalyzed redox system for the biocatalytic reduction of cystine20 Apr 2023US 2023/0124898 A1Wacker Chemie AG
- Product and Process for Mucus Viscosity Normalization19 Aug 2021US 2021/0254025 A1Orpro Therapeutics, Inc.
- Nucleic acid constructs including a txnip promoter for the treatment of disease17 Oct 2019US 2019/0314421 A1Wayne State University
- Nucleic acid constructs including a txnip promoter for the treatment of disease7 Sep 2017US 2017/0252376 A1Wayne State University
Most cited
By later US patents
- Product and process for liquefaction of mucus or sputum12US 7,195,766 B2National Jewish Medical and Research Center · 2007
- Product and process for liquefaction of mucus or sputum7US 7,534,438 B2National Jewish Health · 2009
- Product and process for liquefaction of mucus or sputum4US 8,735,343 B2National Jewish Health · 2014
- Product and process for mucus viscosity normalization3US 9,168,290 B2Orpro Therapeutics, Inc. · 2015
- Product and process for liquefaction of mucus or sputum2US 9,289,471 B2National Jewish Health · 2016